Tomizawa Minoru, Shinozaki Fuminobu, Motoyoshi Yasufumi, Sugiyama Takao, Yamamoto Shigenori, Ishige Naoki
Department of Gastroenterology, National Hospital Organization Shimoshizu Hospital, Yotsukaido, Chiba 284-0003, Japan.
Department of Radiology, National Hospital Organization Shimoshizu Hospital, Yotsukaido, Chiba 284-0003, Japan.
Oncol Lett. 2017 Jan;13(1):258-262. doi: 10.3892/ol.2016.5454. Epub 2016 Nov 30.
Human primary hepatocytes are able to survive in a medium without glucose and arginine that is instead supplemented with galactose and ornithine (hepatocyte selection medium; HSM). This is because the cells produce glucose and arginine by the action of galactokinase (GALK) and ornithine carbamoyltransferase (OTC), respectively. It was expected that hepatocellular carcinoma (HCC) cells do not survive in HSM. In the current study, HCC cell lines (namely HLE, HLF, PLC/PRL/5, Hep3B and HepG2) and human umbilical vascular endothelial cells (HUVECs) were cultured in HSM, and the expression levels of GALK1, GALK2 and OTC were analyzed by reverse transcription-quantitative polymerase chain reaction. HLE, HLF and PLC/PRL/5 cells died on day 11, while Hep3B, HepG2 and HUVECs died on day 7. HLF cells were further analyzed as these cells had lower expression levels of GALK1, GALK2 and OTC compared with adult liver cells, and survived until day 11. In these cells, the expression levels of GALK1, GALK2 and OTC did not change on days 3 and 7 as compared to day 0. In addition, a co-culture of HLF cells with HUVECs was established and the medium was changed to HSM. It was observed that HLF cells and HUVECs in co-culture were damaged in HSM. In summary, HCC cells and HUVECs died in a medium without glucose and arginine that was supplemented with galactose and ornithine. HCC cells and HUVECs were damaged in HSM, suggesting a potential application for treatment with the medium.
人原代肝细胞能够在不含葡萄糖和精氨酸、而是添加了半乳糖和鸟氨酸的培养基(肝细胞选择培养基;HSM)中存活。这是因为细胞分别通过半乳糖激酶(GALK)和鸟氨酸氨甲酰转移酶(OTC)的作用产生葡萄糖和精氨酸。预计肝细胞癌(HCC)细胞在HSM中无法存活。在本研究中,将HCC细胞系(即HLE、HLF、PLC/PRL/5、Hep3B和HepG2)和人脐静脉内皮细胞(HUVECs)培养于HSM中,并通过逆转录-定量聚合酶链反应分析GALK1、GALK2和OTC的表达水平。HLE、HLF和PLC/PRL/5细胞在第11天死亡,而Hep3B、HepG2和HUVECs在第7天死亡。由于HLF细胞与成人肝细胞相比GALK1、GALK2和OTC的表达水平较低且存活至第11天,因此对其进行了进一步分析。在这些细胞中,与第0天相比,GALK1、GALK2和OTC的表达水平在第3天和第7天没有变化。此外,建立了HLF细胞与HUVECs的共培养体系,并将培养基更换为HSM。观察到共培养的HLF细胞和HUVECs在HSM中受到损伤。总之,HCC细胞和HUVECs在不含葡萄糖和精氨酸、而是添加了半乳糖和鸟氨酸的培养基中死亡。HCC细胞和HUVECs在HSM中受到损伤,提示该培养基在治疗方面具有潜在应用价值。